Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second-generation adenovirus vectors

Q Wang1, M H Finer

  • 1Cell Genesys Inc., Foster City, California 94404, USA.

Nature Medicine
|June 1, 1996
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The RNase Protection Assay.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

T-cell killing of heterogenous tumor or viral targets with bispecific chimeric immune receptors.

Cancer gene therapy·2000
Same author

Impact of chimeric immune receptor extracellular protein domains on T cell function.

Gene therapy·1999
Same author

Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor.

Human gene therapy·1999
Same author

Power Doppler imaging findings in multilocular giant parathyroid adenoma which caused hypercalcaemic crisis.

The Journal of laryngology and otology·1998
Same author

Cerebral vasodilating capacity during forebrain ischemia: effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthase.

Neuroreport·1998
Same journal

Longitudinal multiomics profiling of extracorporeal cross-circulation with pig liver xenografts in human decedents.

Nature medicine·2026
Same journal

Spatiotemporal diffusion of the 2024 Oropouche outbreak in Cuba.

Nature medicine·2026
Same journal

Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial.

Nature medicine·2026
Same journal

Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Nature medicine·2026
Same journal

Data rights are the missing pillar for modernizing consent in medicine.

Nature medicine·2026
Same journal

Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

Nature medicine·2026
See all related articles